The BRIGHTER trial: A phase 3 randomized double-blind study of napabucasin (NAPA) plus paclitaxel (PTX) versus placebo (PBO) plus PTX in patients (pts) with pretreated advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma

Abstract only

Saved in:

Bibliographic Details
Published in	Journal of clinical oncology Vol. 36; no. 15_suppl; p. 4010
Main Authors	Shah, Manish A., Shitara, Kohei, Lordick, Florian, Bang, Yung-Jue, Tebbutt, Niall C., Metges, Jean-Philippe, Muro, Kei, Shen, Lin, Tjulandin, Sergei, Hays, John L., Xu, Rui-hua, Fontaine, Marilyn, Brooks, Emily, Xu, Bo, Li, Wei, Li, Chiang, Borodyansky, Laura, Van Cutsem, Eric
Format	Journal Article
Language	English
Published	20.05.2018
Online Access	Get full text

Loading…